Global Ranitidine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ranitidine Market Research Report 2024
Ranitidine is a histamine H2 antagonists and available as both over-the-counter (OTC) and prescription drug, indicated in the treatment of gastroesophageal reflux disease (GERD). Ranitidine decreases the acid production from stomach for up to 12 hours. Also, ranitidine is commonly used in erosive esophagitis, peptide ulcer disease, and Zollinger–Ellison syndrome. It could be taken orally or intravenously.
According to Mr Accuracy reports’s new survey, global Ranitidine market is projected to reach US$ 387.1 million in 2034, increasing from US$ 347.8 million in 2024, with the CAGR of 1.6% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ranitidine market research.
Key manufacturers engaged in the Ranitidine industry include GSK, Merck, Boehringer Ingelheim, Strides Pharma Science Limited (Strides Shasun), Sun Pharma and Tocris Bioscience (R & D Systems), etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Ranitidine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Ranitidine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ranitidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
GSK
Merck
Boehringer Ingelheim
Strides Pharma Science Limited (Strides Shasun)
Sun Pharma
Tocris Bioscience (R & D Systems)
Segment by Type
Tablet
Syrup
Injection
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Ranitidine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Ranitidine market is projected to reach US$ 387.1 million in 2034, increasing from US$ 347.8 million in 2024, with the CAGR of 1.6% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ranitidine market research.
Key manufacturers engaged in the Ranitidine industry include GSK, Merck, Boehringer Ingelheim, Strides Pharma Science Limited (Strides Shasun), Sun Pharma and Tocris Bioscience (R & D Systems), etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Ranitidine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Ranitidine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ranitidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GSK
Merck
Boehringer Ingelheim
Strides Pharma Science Limited (Strides Shasun)
Sun Pharma
Tocris Bioscience (R & D Systems)
Segment by Type
Tablet
Syrup
Injection
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Ranitidine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source